This is the first COVID-19 vaccine that has received final approval from the U.S. Food and Drug Administration.
Food and Drug Administration (FDA) on Monday finally approved for use a coronavirus vaccine developed by the American company Pfizer and its German partner BioNTech. This is reported in the press release of the regulator.
Pfizer’s drug is the first COVID-19 vaccine to receive final FDA approval. Before that, in December 2020, Pfizer’s vaccine was certified by the FDA under an accelerated procedure for use in emergency circumstances. Similar approval was later received by Moderna and Johnson & Johnson vaccines.
“Today, the FDA approved the first COVID-19 vaccine. The drug was known as [the vaccine for] COVID-19 by Pfizer/BioNTech, now it will be presented on the market under the name Comirnaty [as a drug] for the prevention of COVID-19 for people aged 16 years and older,” the report says.
As noted in the press release, within the framework of the previously issued permission for the use of this vaccine in emergency circumstances, it will still be available for people aged 12 to 15 years, and the permission for the use of a booster dose of the drug for people with weakened immunity will also continue to operate.